Overview and potential role of omega-3 in COVID-19.

Obesity is a modifiable inflammatory commodity that has been linked to higher morbidity and mortality to those that contract novel viruses, such as H1N1 and SARS-CoV-2. Loss of life and the high cost of obesity highlights the need to focus on preventative measures. This article will discuss obesity as a crucial comorbid inflammatory condition during COVID-19 pandemic, focus on the mechanisms that may contribute to the likely benefits of omega-3 and provide potential recommendations to promote strategies for wellness.

A Review of Interventions for Drowning Prevention Among Adults.

Adult drowning is a complex and multifactorial public health challenge requiring community, national and global efforts to mitigate impacts. This study updates the evidence base for public health interventions that address adult fatal and non-fatal drowning. A systematic review was undertaken of the peer-reviewed literature for English-language primary studies published between 2011 and 2021describing a drowning intervention with adults.

Prevalence of 25(OH)D insufficiency and overweight/obesity in an adult population from the Central Italy.

Background: Nowadays, excess weight is reaching epidemic proportions and it is necessary to identify patients at greater metabolic risk, in order to determine the most suitable pharmacological and dietetic options. On the other hand, vitamin D insufficiency (or hypovitaminosis D) is prevalent in obese patients. It most commonly occurs in people with inadequate sunlight exposure and nutritional intake of vitamin D, disorders limiting vitamin D absorption, and conditions impairing vitamin D conversion into active metabolite, including certain liver, kidney, and hereditary disorders.

Effect of Third-Generation Beta Blockers on Weight Loss in a Population of Overweight-Obese Subjects in a Controlled Dietary Regimen.

Background: Overweight and obesity often develop in individuals with genetic susceptibility and concomitant risk factors; however, medications can represent precipitating factors in some cases: evidence suggests that some antihypertensive drugs can adversely affect energy homeostasis and metabolism.

Aim: The primary aim of this study was to investigate whether long-term therapy with a beta blocker impairs weight loss during a period of appropriate personalized hypocaloric diet and standardized physical activity in overweight and obese hypertensive patients in monotherapy and without comorbidities, compared to other antihypertensive drugs and to a control group not taking antihypertensive therapy. .

COVID-19 and Obesity: Overlapping of Two Pandemics.

Background: The coronavirus disease 2019 (COVID-19) pandemic has recently led to worldwide research efforts to identify subjects at greater risk of developing more severe illness: overall obesity displayed a strong correlation with critical illness and major severity of COVID-19 manifestations.

Summary: Obesity and metabolic disorders are closely linked to chronic systemic inflammation. The adipose tissue constitutes a source of cytokines, which configure a low-grade inflammation and a hypercoagulation status; in addition, diagnosis and care of obese patients are often complicated by excess weight and ventilation difficulties.